239 related articles for article (PubMed ID: 1909923)
1. Effects of haloperidol administration on in vivo extracellular dopamine in striatum and prefrontal cortex after partial dopamine lesions.
Bean AJ; Roth RH
Brain Res; 1991 May; 549(1):155-8. PubMed ID: 1909923
[TBL] [Abstract][Full Text] [Related]
2. Environmental stress increases extracellular dopamine in striatum of 6-hydroxydopamine-treated rats: in vivo microdialysis studies.
Keefe KA; Stricker EM; Zigmond MJ; Abercrombie ED
Brain Res; 1990 Sep; 527(2):350-3. PubMed ID: 2123730
[TBL] [Abstract][Full Text] [Related]
3. Dopamine release in rat striatum: physiological coupling to tyrosine supply.
During MJ; Acworth IN; Wurtman RJ
J Neurochem; 1989 May; 52(5):1449-54. PubMed ID: 2496199
[TBL] [Abstract][Full Text] [Related]
4. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.
Zhang WQ; Tilson HA; Nanry KP; Hudson PM; Hong JS; Stachowiak MK
Brain Res; 1988 Oct; 461(2):335-42. PubMed ID: 3141002
[TBL] [Abstract][Full Text] [Related]
5. Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals.
Carboni E; Tanda GL; Frau R; Di Chiara G
J Neurochem; 1990 Sep; 55(3):1067-70. PubMed ID: 2117046
[TBL] [Abstract][Full Text] [Related]
6. Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats.
Abercrombie ED; Bonatz AE; Zigmond MJ
Brain Res; 1990 Aug; 525(1):36-44. PubMed ID: 2123121
[TBL] [Abstract][Full Text] [Related]
7. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological, biochemical, and behavioral studies of acute haloperidol-induced depolarization block of nigral dopamine neurons.
Hollerman JR; Abercrombie ED; Grace AA
Neuroscience; 1992; 47(3):589-601. PubMed ID: 1584410
[TBL] [Abstract][Full Text] [Related]
9. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
Broderick PA; Piercey MF
J Neural Transm (Vienna); 1998; 105(6-7):749-67. PubMed ID: 9826116
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis.
Zetterström T; Herrera-Marschitz M; Ungerstedt U
Brain Res; 1986 Jun; 376(1):1-7. PubMed ID: 3087581
[TBL] [Abstract][Full Text] [Related]
11. Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems.
Rosin DL; Clark WA; Goldstein M; Roth RH; Deutch AY
Neuroscience; 1992 Jun; 48(4):831-9. PubMed ID: 1352864
[TBL] [Abstract][Full Text] [Related]
12. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation.
Korf J; Sebens JB
J Neurochem; 1987 Feb; 48(2):516-21. PubMed ID: 2878979
[TBL] [Abstract][Full Text] [Related]
13. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.
Snyder GL; Keller RW; Zigmond MJ
J Pharmacol Exp Ther; 1990 May; 253(2):867-76. PubMed ID: 2110978
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of striatal acetylcholine release by serotonin and dopamine after the intracerebral administration of 6-hydroxydopamine to neonatal rats.
Jackson D; Bruno JP; Stachowiak MK; Zigmond MJ
Brain Res; 1988 Aug; 457(2):267-73. PubMed ID: 3146404
[TBL] [Abstract][Full Text] [Related]
15. Activation of striatal dopaminergic grafts by haloperidol.
Herman JP; Choulli K; Le Moal M
Brain Res Bull; 1985 Dec; 15(6):543-6. PubMed ID: 3936594
[TBL] [Abstract][Full Text] [Related]
16. Hypophysectomy does not alter the increase in striatal dopamine receptor density produced by 6-hydroxydopamine lesions in male rats.
Hruska RE
Neurosci Lett; 1986 Jul; 68(2):207-10. PubMed ID: 3092152
[TBL] [Abstract][Full Text] [Related]
17. Direct in vivo electrochemical monitoring of dopamine release in response to neuroleptic drugs.
Blaha CD; Lane RF
Eur J Pharmacol; 1984 Feb; 98(1):113-7. PubMed ID: 6143672
[TBL] [Abstract][Full Text] [Related]
18. Utilization of microdialysis for assessing the release of mesotelencephalic dopamine following clozapine and other antipsychotic drugs.
Moghaddam B; Bunney BS
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14 Suppl():S51-7. PubMed ID: 2097674
[TBL] [Abstract][Full Text] [Related]
19. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
20. Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress.
Deutch AY; Clark WA; Roth RH
Brain Res; 1990 Jun; 521(1-2):311-5. PubMed ID: 2119850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
